Deoxygedunin, a Natural Product with Potent Neurotrophic Activity in Mice
Open accessThe DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Abstract
Gedunin, a family of natural products from the Indian neem tree, possess a variety of biological activities. Here we report the discovery of deoxygedunin, which activates the mouse TrkB receptor and its downstream signaling cascades. Deoxygedunin is orally available and activates TrkB in mouse brain in a BDNF-independent way. Strikingly, it prevents the degeneration of vestibular ganglion in BDNF -/- pups. Moreover, deoxygedunin robustly protects rat neurons from cell death in a TrkB-dependent manner. Further, administration of deoxygedunin into mice displays potent neuroprotective, anti-depressant and learning enhancement effects, all of which are mediated by the TrkB receptor. Hence, deoxygedunin imitates BDNF's biological activities through activating TrkB, providing a powerful therapeutic tool for treatment of various neurological diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3 Deoxygedunin binds TrkB ECD and elicits its dimerization. (A) [3H]deoxygedunin binds the ECD but not ICD of TrkB receptor. In vitro binding assay with purified TrkB ECD or ICD (10 µg) and [3H]deoxygedunin (upper panel). In vitro binding assay with purified fragments of TrkB ECD (10 µg) and [3H]deoxygedunin. (B) Determination of binding constant. Binding curve (upper panel). Scatchard plot analysis revealed that deoxygedunin binds TrkB with binding constant of 1.4 µM (lower panel). (C) Deoxygedunin provokes TrkB dimerization. mGST-TrkB and HA-TrkB were cotransfected into HEK293 cells, treated with 0.5 µM various gedunins for 30 min. GST-TrkB was pulled down by glutathione beads, the coprecipitated proteins were analyzed with anti-HA HRP antibody. (D) Deoxygedunin induces TrkB autophosphorylation. HEK 293 cells were transfected with various Trk receptors, followed by deoxygedunin treatment for 30 min. Cell lysates were analyzed by immunoblotting assay.](https://figures.cochat.ai/paper-figures/f132d16c95da475abafe8a3251d8f21e/deoxygedunin-a-natural-product-with-potent-neurotrophic-activity-in-mice-figure-3.jpg)




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Its derivative, deoxygedunin, seems to be a promising selective TrkB agonist, showing protective effects against apoptosis, both in vitro, in hippocampal neurons incubated with a toxic dose of DMSO, and in vivo, in mice that received kainic acid (Jang et al. 2010).”
From Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression (2018) · cites this paper as Jang et al. 2010
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Antidepressant effects of deoxygedunin have also been shown after subchronic treatment, displaying reduced immobility in the FST (Jang et al. 2010).”
From Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression (2018) · cites this paper as Jang et al. 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lamb, J., Crawford, E. D., Peck, D., Modell, J. W., Blat, I. C., Wrobel, M. J., Lerner, J., Brunet, J.-P., Subramanian, A., Ross, K. N., et al. (2006) · Science · doi:10.1126/science.1132939 · Cited by 5,257
Generalized lacZ expression with the ROSA26 Cre reporter strain
Soriano, P. (1999) · Nature Genetics · doi:10.1038/5007 · Cited by 4,859
Behavioral despair in mice: a primary screening test for antidepressants.
Porsolt, R. D., Bertin, A., & Jalfre, M. (1977) · PubMed · Cited by 4,013
The Nerve Growth Factor 35 Years Later
Levi-Montalcini, R. (1987) · Science · doi:10.1126/science.3306916 · Cited by 3,125
Trk Receptors: Roles in Neuronal Signal Transduction
Huang, E. J., & Reichardt, L. F. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161629 · Cited by 2,537 · cited 8×
“The cell lysates were analyzed by immunoblotting with anti-p-TrkB, anti-p-TrkA and anti-active caspase-3 etc. (B) Deoxygedunin diminishes caspase-3 activation regardless of TrkC genotype.”
BackgroundInfluentialPhysiology of the Neurotrophins
Lewin, G. R., & Barde, Y.-A. (1996) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.19.030196.001445 · Cited by 1,955
Neurotrophin signal transduction in the nervous system
Kaplan, D. R., & Miller, F. D. (2000) · Current Opinion in Neurobiology · doi:10.1016/s0959-4388(00)00092-1 · Cited by 1,944 · cited 8×
“The cell lysates were analyzed by immunoblotting with anti-p-TrkB, anti-p-TrkA and anti-active caspase-3 etc. (B) Deoxygedunin diminishes caspase-3 activation regardless of TrkC genotype.”
BackgroundInfluentialBrain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression
Shirayama, Y., Chen, A. C.-H., Nakagawa, S., Russell, D. S., & Duman, R. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03251.2002 · Cited by 1,654
Assessing antidepressant activity in rodents: recent developments and future needs
Cryan, J. F., Markou, A., & Lucki, I. (2002) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(02)02017-5 · Cited by 1,551 · cited 1×
“screening of potential antidepressant drugs and is widely used to measure antidepressant activity [32,33].”
BackgroundGenetic variant BDNF (Val66Met) polymorphism alters anxiety-related behavior
Chen, Z.-Y., Jing, D., Bath, K. G., Ieraci, A., Khan, T., Siao, C.-J., Herrera, D. G., Toth, M., Yang, C., McEwen, B. S., et al. (2006) · Science · doi:10.1126/science.1129663 · Cited by 1,340
Cited by
BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases
Lu, B., Nagappan, G., Guan, X., Nathan, P. J., & Wren, P. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3505 · Cited by 743
Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression
Levy, M. J. F., Boulle, F., Steinbusch, H. W., van den Hove, D. L. A., Kenis, G., & Lanfumey, L. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4950-4 · Cited by 308
Longo, F. M., & Massa, S. M. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4024 · Cited by 298
Fear extinction and BDNF: translating animal models of PTSD to the clinic
Andero, R., & Ressler, K. J. (2012) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2012.00801.x · Cited by 276
Self-citationTrkB Receptor Signalling: Implications in Neurodegenerative, Psychiatric and Proliferative Disorders
Gupta, V., You, Y., Gupta, V., Klistorner, A., & Graham, S. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms140510122 · Cited by 258
Andero, R., Choi, D. C., & Ressler, K. J. (2014) · Progress in Molecular Biology and Translational Science · doi:10.1016/b978-0-12-420170-5.00006-4 · Cited by 182
Self-citationRichner, M., Ulrichsen, M., Elmegaard, S. L., Dieu, R., Pallesen, L. T., & Vaegter, C. B. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8706-9 · Cited by 161
TrkB/BDNF signaling pathway and its small molecular agonists in CNS injury
Wang, Y., Liang, J., Xu, B., Yang, J., Wu, Z., & Cheng, L. (2024) · Life Sciences · doi:10.1016/j.lfs.2023.122282 · Cited by 152
Using the Heat-Shock Response To Discover Anticancer Compounds that Target Protein Homeostasis
Santagata, S., Xu, Y.-M., Wijeratne, E. M. K., Kontnik, R., Rooney, C., Perley, C. C., Kwon, H., Clardy, J., Kesari, S., Whitesell, L., et al. (2012) · ACS Chemical Biology · doi:10.1021/cb200353m · Cited by 147
Neurotrophic Natural Products: Chemistry and Biology
Xu, J., Lacoske, M. H., & Theodorakis, E. A. (2013) · Angewandte Chemie International Edition · doi:10.1002/anie.201302268 · Cited by 131
Molecular mechanisms of brain-derived neurotrophic factor in neuro-protection: Recent developments
Zhao, H., Alam, A., San, C.-Y., Eguchi, S., Chen, Q., Lian, Q., & Ma, D. (2017) · Brain Research · doi:10.1016/j.brainres.2017.03.029 · Cited by 122
Kazim, S. F., & Iqbal, K. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0119-y · Cited by 115
Liu, X., Obianyo, O., Chan, C. B., Huang, J., Xue, S., Yang, J. J., Zeng, F., Goodman, M., & Ye, K. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.562561 · Cited by 113
Self-citationBrain-derived neurotrophic factor in the airways
Prakash, Y. S., & Martin, R. J. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.02.006 · Cited by 105
Gupta, V., You, Y., Li, J. C., Klistorner, A. I., & Graham, S. L. (2012) · Journal of Molecular Neuroscience · doi:10.1007/s12031-012-9899-x · Cited by 97
Multiplex quantitative assays indicate a need for reevaluating reported small-molecule TrkB agonists
Boltaev, U., Meyer, Y., Tolibzoda, F., Jacques, T., Gassaway, M., Xu, Q., Wagner, F., Zhang, Y.-L., Palmer, M., Holson, E., et al. (2017) · Science Signaling · doi:10.1126/scisignal.aal1670 · Cited by 94
Chitranshi, N., Dheer, Y., Abbasi, M., You, Y., Graham, S. L., & Gupta, V. (2018) · Current Neuropharmacology · doi:10.2174/1570159x16666180419121247 · Cited by 94
Small-molecule trkB agonists promote axon regeneration in cut peripheral nerves
English, A. W., Liu, K., Nicolini, J. M., Mulligan, A. M., & Ye, K. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303646110 · Cited by 91
Self-citationNaoi, M., Shamoto‐Nagai, M., & Maruyama, W. (2019) · Future Neurology · doi:10.2217/fnl-2018-0028 · Cited by 87
Liu, X., Qi, Q., Xiao, G., Li, J., Luo, H. R., & Ye, K. (2013) · Pharmacology · doi:10.1159/000346920 · Cited by 76
Self-citationGundimeda, U., McNeill, T. H., Fan, T., Deng, R., Rayudu, D. V., Chen, Z., Cadenas, E., & Gopalakrishna, R. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.01.166 · Cited by 72
Nie, S., Yan, X., Chen, G., Ma, K., Han, C., Guo, Z., Zhang, Z., Ye, K., & Cao, X. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.08.016 · Cited by 69
Self-citationSchuppe, A. W., & Newhouse, T. R. (2017) · Journal of the American Chemical Society · doi:10.1021/jacs.6b12268 · Cited by 68
Illicium Sesquiterpenes: Divergent Synthetic Strategy and Neurotrophic Activity Studies
Trzoss, L., Xu, J., Lacoske, M. H., Mobley, W. C., & Theodorakis, E. A. (2013) · Chemistry - A European Journal · doi:10.1002/chem.201300198 · Cited by 64
Liu, X., Chan, C.-B., Qi, Q., Xiao, G., Luo, H. R., He, X., & Ye, K. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm301099x · Cited by 60
Self-citationSharma, V., Singh, T. G., Kaur, A., Mannan, A., & Dhiman, S. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03755-1 · Cited by 59
Unlocking Alzheimer’s Disease: The Role of BDNF Signaling in Neuropathology and Treatment
Alqahtani, S. M., Al-Kuraishy, H. M., Al-Gareeb, A. I., Albuhadily, A. K., Alexiou, A. T., Papadakis, M., Hemeda, L. R., Faheem, S. A., & Batiha, G. E. (2025) · NeuroMolecular Medicine · doi:10.1007/s12017-025-08857-x · Cited by 59
BDNF / TrkB activators in Parkinson's disease: A new therapeutic strategy
Ali, N. H., Al-Kuraishy, H. M., Al-Gareeb, A. I., Alexiou, A. T., Papadakis, M., AlAseeri, A. A., Alruwaili, M., Saad, H. M., & Batiha, G. E. (2024) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18368 · Cited by 58
Concise Chemoenzymatic Synthesis of Gedunin
Li, J., Chen, F., & Renata, H. (2022) · Journal of the American Chemical Society · doi:10.1021/jacs.2c09048 · Cited by 58
Potential benefits of phytochemicals from Azadirachta indica against neurological disorders
Sandhir, R., Khurana, M., & Singhal, N. K. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105023 · Cited by 57
Neurotrophin receptor agonists and antagonists as therapeutic agents: An evolving paradigm
Josephy-Hernandez, S., Jmaeff, S., Pirvulescu, I., Aboulkassim, T., & Saragovi, H. U. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.08.004 · Cited by 54
Therapeutic potential of a TrkB agonistic antibody for Alzheimer's disease
Wang, S., Yao, H., Xu, Y., Hao, R., Zhang, W., Liu, H., Huang, Y., Guo, W., & Lu, B. (2020) · Theranostics · doi:10.7150/thno.44165 · Cited by 53
N -acetyl serotonin derivatives as potent neuroprotectants for retinas
Shen, J., Ghai, K., Sompol, P., Liu, X., Cao, X., Iuvone, P. M., & Ye, K. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1119201109 · Cited by 51
Self-citationBasavarajappa, D. K., Galindo‐Romero, C., Gupta, V., Agudo‐Barriuso, M., Gupta, V. B., Graham, S. L., & Chitranshi, N. (2023) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2023.101216 · Cited by 51
Highly Enantioselective Catalytic Synthesis of Neurite Growth-Promoting Secoyohimbanes
Antonchick, A. P., López-Tosco, S., Parga, J. A., Sievers, S., Schürmann, M., Preut, H., Höing, S., Schöler, H. R., Sterneckert, J. L., Rauh, D., et al. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.03.011 · Cited by 51
Pluskal, T., & Weng, J. (2018) · Chemical Society Reviews · doi:10.1039/c7cs00411g · Cited by 49
Neurotrophin-targeted therapeutics: A gateway to cognition and more?
Nordvall, G., Forsell, P., & Sandin, J. (2022) · Drug Discovery Today · doi:10.1016/j.drudis.2022.07.003 · Cited by 48
Yang, T., Massa, S. M., Tran, K. C., Simmons, D. A., Rajadas, J., Zeng, A. Y., Jang, T., Carsanaro, S., & Longo, F. M. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.06.015 · Cited by 47
TrkB transmembrane domain: bridging structural understanding with therapeutic strategy
Enkavi, G., Girych, M., Moliner, R., Vattulainen, I., & Castrén, E. (2024) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2024.02.001 · Cited by 44
He, J., Xiang, Z., Zhu, X., Ai, Z., Shen, J., Huang, T., Liu, L., Ji, W., & Li, T. (2016) · Scientific Reports · doi:10.1038/srep34339 · Cited by 44
Modulating Neurotrophin Receptor Signaling as a Therapeutic Strategy for Huntington’s Disease
Simmons, D. A. (2017) · Journal of Huntington s Disease · doi:10.3233/jhd-170275 · Cited by 43
Pankiewicz, P., Szybiński, M., Kisielewska, K., Gołębiowski, F., Krzemiński, P., Rutkowska-Włodarczyk, I., Moszczyński-Pętkowski, R., Gurba-Bryśkiewicz, L., Delis, M., Mulewski, K., et al. (2021) · Pharmaceuticals · doi:10.3390/ph14080704 · Cited by 42
“7,8-DHF was originally described in the literature as a bioavailable compound that can pass through the BBB and demonstrated a functional effect in a TrkB-dependent manner after acute (5 mg/kg in TrkB F616A knock-in mice) and 14-day treatment (exposed to C57BL/6 in drinking water) [39].”
BackgroundMethodInfluentialNie, S., Ma, K., Sun, M., Lee, M., Yang, T., Chen, G., Zhang, Z., Zhang, Z., & Cao, X. (2019) · Parkinson s Disease · doi:10.1155/2019/9193534 · Cited by 41
Balancing neurotrophin pathway and sortilin function: Its role in human disease
Al-Yozbaki, M., Acha‐Sagredo, A., George, A., Liloglou, T., & Wilson, C. M. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188429 · Cited by 41
Therapeutic potential of a TrkB agonistic antibody for ischemic brain injury
Han, F., Guan, X.-M., Guo, W., & Lu, B. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.04.009 · Cited by 40
Novel small molecule activators of the Trk family of receptor tyrosine kinases
Obianyo, O., & Ye, K. (2013) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2012.08.021 · Cited by 39
Self-citationWithanolide A: synthesis and structural requirements for neurite outgrowth
Liffert, R., Hoecker, J., Jana, C. K., Woods, T. M., Burch, P., Jessen, H. J., Neuburger, M. A., & Gademann, K. (2013) · Chemical Science · doi:10.1039/c3sc50653c · Cited by 37
Therapeutic Targeting Strategies for Early- to Late-Staged Alzheimer’s Disease
Kang, Y. J., Diep, Y. N., Tran, M., & Cho, H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249591 · Cited by 36
“Other examples involve deoxygedunin [67], LM22A-4 [68], and bicyclic BDNF loop mimetics [248] that have proven their BDNF neurotrophic effects in AD.”
BackgroundChapleau, C. A., Lane, J. B., Pozzo‐Miller, L. D., & Percy, A. K. (2013) · Current Clinical Pharmacology · doi:10.2174/15748847113086660069 · Cited by 36
Nishijima, E., Honda, S., Kitamura, Y., Namekata, K., Kimura, A. K., Guo, X., Azuchi, Y., Harada, C., Murakami, A., Matsuda, A., et al. (2022) · Molecular Therapy · doi:10.1016/j.ymthe.2022.11.018 · Cited by 35
Advances in intravesical therapy for urinary tract disorders
Tyagi, P., Kashyap, M. P., Hensley, H. H., & Yoshimura, N. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2016.1100166 · Cited by 34
Froestl, W., Pfeifer, A., & Muhs, A. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121729 · Cited by 32
Diamantopoulou, E., Baxendale, S., de León, A. D. L. V., Asad, A., Holdsworth, C. J., Abbas, L., Gillet, V. J., Wiggin, G. R., & Whitfield, T. T. (2019) · eLife · doi:10.7554/elife.44889 · Cited by 31
Epigenetic-Mediated Decline in Synaptic Plasticity During Aging
Mendelsohn, A. R., & Larrick, J. W. (2012) · Rejuvenation Research · doi:10.1089/rej.2012.1312 · Cited by 28
Vaibhav, K., Shrivastava, P., Khan, A., Javed, H., Tabassum, R., Ahmed, M. E., Khan, M. B., Khan, M. M., Islam, F., Ahmad, S., et al. (2012) · Neurological Sciences · doi:10.1007/s10072-012-1238-z · Cited by 28
TrkB agonists prevent postischemic emergence of refractory neonatal seizures in mice
Kipnis, P. A., Sullivan, B. J., Carter, B. M., & Kadam, S. D. (2020) · JCI Insight · doi:10.1172/jci.insight.136007 · Cited by 27
Wisutsitthiwong, C., Buranaruk, C., Pudhom, K., & Palaga, T. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.10.073 · Cited by 25
Mishra, K., Rana, R., Tripathi, S., Siddiqui, S., Yadav, P. K., Yadav, P. N., & Chourasia, M. K. (2023) · Neurochemical Research · doi:10.1007/s11064-023-03955-3 · Cited by 21
Utilization of in situ ELISA method for examining Trk receptor phosphorylation in cultured cells
Antila, H., Autio, H., Turunen, L., Harju, K., Tammela, P., Wennerberg, K., Yli‐Kauhaluoma, J. T., Huttunen, H. J., Ċastrén, E., & Rantamäki, T. (2013) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2013.11.001 · Cited by 20
BDNF Outperforms TrkB Agonist 7,8,3′-THF in Preserving the Auditory Nerve in Deafened Guinea Pigs
Vink, H. A., van Dorp, W. C., Thomeer, H. G. X. M., Versnel, H., & Ramekers, D. (2020) · Brain Sciences · doi:10.3390/brainsci10110787 · Cited by 20
The regulatory role of the BDNF/TrkB pathway in organ and tissue fibrosis.
Hang, P., Ge, F.-Q., Li, P., Liu, J., Zhu, H., & Zhao, J. (2021) · PubMed · doi:10.14670/hh-18-368 · Cited by 20
Fukuda, M., Takatori, A., Nakamura, Y., Suganami, A., Hoshino, T., Tamura, Y., & Nakagawara, A. (2016) · Neurochemistry International · doi:10.1016/j.neuint.2016.04.017 · Cited by 19
Fan, C.-H., Lin, C.-W., Huang, H.-J., Lee‐Chen, G., Sun, Y., Lin, W., Chen, C., Chang, K., Su, M., & Hsieh‐Li, H. M. (2020) · Psychopharmacology · doi:10.1007/s00213-020-05602-z · Cited by 19
Nimbolide attenuate the lipid accumulation, oxidative stress and antioxidant in primary hepatocytes
Alshammari, G. M., Balakrishnan, A., & Chinnasamy, T. (2017) · Molecular Biology Reports · doi:10.1007/s11033-017-4132-1 · Cited by 19
Neurotrophe Naturstoffe – ihre Chemie und Biologie
Xu, J., Lacoske, M. H., & Theodorakis, E. A. (2013) · Angewandte Chemie · doi:10.1002/ange.201302268 · Cited by 18
Sengupta, R., Barone, A. K., Marasa, J. C., Taylor, S. J., Jackson, E., Warrington, N. M., Rao, S., Kim, A. H., Leonard, J. R., Piwnica-Worms, D. R., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4957 · Cited by 18
Endogenous Neuroprotective Molecules and Their Mechanisms in the Central Nervous System
Hayashi, H., & Takagi, N. (2015) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b15-00361 · Cited by 17
Ali, A., Babar, Q., Saeed, A., Sergi, D., Naumovski, N., Ahmed, I. A. M., Shamlan, G. H., Hafiz, H., Manzoor, M. F., Trafiałek, J., et al. (2025) · Food Science & Nutrition · doi:10.1002/fsn3.70385 · Cited by 16
Hannan, M. A., Haque, M. N., Dash, R., Alam, M., & Moon, I. S. (2019) · Scientific Reports · doi:10.1038/s41598-019-55364-8 · Cited by 16
Sun, Y., Dong, Z., Jin, T., Ang, K.-H., Huang, M., Haston, K. M., Peng, J., Zhong, T. P., Finkbeiner, S. M., Weiss, W. A., et al. (2013) · eLife · doi:10.7554/elife.00508 · Cited by 16
Mueller, B., Dorota, L., & Raghu, R. (2011) · InTech eBooks · doi:10.5772/18465 · Cited by 15
Positive Allosteric Modulators of Trk Receptors for the Treatment of Alzheimer’s Disease
Forsell, P., Parrado Fernández, C., Nilsson, B., Sandin, J., Nordvall, G., & Segerdahl, M. (2024) · Pharmaceuticals · doi:10.3390/ph17080997 · Cited by 14
Small-Molecule Trk Agonists: Where Do We Go from Here?
Thompson, T. S., Sefiani, A., & Burgess, K. (2025) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c02365 · Cited by 13
“Compounds found to exhibit neurotrophic activity in this manner include gambogic amide 52 (TrkA agonist), amitripty-line 53 (A and B agonist), and the B agonists N -acetyl serotonin 54 (NAS), deoxygedunin, 55 and 7,8-dihydroxyflavone (7,8-DHF).”
Neuroprotective effects of flavonoids
Taghizadieh, M., Modiri, N., Salmaninejad, A., Khayami, R., Taheri, F., Moghoofei, M., Khatami, A., Azhdari, S., Bayat, M., Samadi-khouzani, A., et al. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-824467-8.00016-4 · Cited by 12
Kramer, B., Tropitzsch, A. S., Müller, M. C., & Löwenheim, H. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.05.053 · Cited by 11
ENGLISH, A. W., Carrasco, D. I., Hoffman, D., Isaacson, R. H., Kang, S. S., Khan, S., Liu, X., & Ye, K. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.857664 · Cited by 11
Self-citationDynamic Structure of NGF and proNGF Complexed with p75NTR: Pro-Peptide Effect
Pimenta, A. C., Dourado, D. F. A. R., Martins, J. M. D. S., Melo, A., Cordeiro, M. N. D. S., Almeida, R. D., Morra, G., & Moreira, I. S. (2014) · Journal of Chemical Information and Modeling · doi:10.1021/ci500101n · Cited by 10
Development of Precision Small-Molecule Proneurotrophic Therapies for Neurodegenerative Diseases
Janssens, J., Lu, D., Ni, B., Chadwick, W., Siddiqui, S., Azmi, A. S., Etienne, H., Jushaj, A., van Gastel, J., Martin, B., et al. (2016) · Vitamins and hormones · doi:10.1016/bs.vh.2016.10.006 · Cited by 9
Age-Dependency of Neurite Outgrowth in Postnatal Mouse Cochlear Spiral Ganglion Explants
Frick, C., Fink, S., Schmidbauer, D., Rousset, F., Eickhoff, H., Tropitzsch, A. S., Kramer, B., Senn, P., Glueckert, R., Rask‐Andersen, H., et al. (2020) · Brain Sciences · doi:10.3390/brainsci10090580 · Cited by 9
MAKINO, A., Iinuma, M., Fukumitsu, H., Soumiya, H., Furukawa, Y., & Furukawa, S. (2013) · Biomedical Research · doi:10.2220/biomedres.34.259 · Cited by 9
Azam, H., Khan, M. T., Lodhi, M. S., Sadiqa, A., & Yasin, T. (2023) · International Journal of Applied and Experimental Biology · doi:10.56612/ijaeb.v1i1.58 · Cited by 6
Jiao, X., Zhang, F., Guo, L., Guo, Z.-Y., Fu, Q.-S., Bi, C.-C., Hou, X.-W., Wang, N., Zhou, J., & Li, Y. (2024) · Aquaculture · doi:10.1016/j.aquaculture.2024.741603 · Cited by 5
Neuritogenic Surfaces using Natural Product Analogs
Burch, P., Schmid, F., & Gademann, K. (2014) · Advanced Healthcare Materials · doi:10.1002/adhm.201300671 · Cited by 5
Zhu, J., Zou, J., Li, F., Gao, Y., Wang, L., Sun, Y. E., Zhu, J., Zhang, X., Xue, K., Li, G., et al. (2022) · MedComm – Future Medicine · doi:10.1002/mef2.15 · Cited by 4
BDNF and Senile Cognitive Decline
Semenov, D. G., & Belyakov, A. V. (2022) · Neuroscience and Behavioral Physiology · doi:10.1007/s11055-022-01236-0 · Cited by 4
Chihara, Y., Iwasaki, S., Kondo, K., & Yamasoba, T. (2011) · Brain Research · doi:10.1016/j.brainres.2011.06.058 · Cited by 4
Yadav, R. N., Dey, S., Hossain, M. F., Ray, D., Banik, B. K., Schmidt, L. C., & Singh, V. (2026) · RSC Medicinal Chemistry · doi:10.1039/d5md01011j · Cited by 4
An Overview of the Bioactivities of Gedunin
Ong, Y. S., Khaw, K. Y., Tan, L. T., Yew, P. N., Tan, K.-B., Yap, W. H., Tang, S. Y., Low, L. E., Lee, L., & Goh, B.-H. (2020) · Advanced structured materials · doi:10.1007/978-3-030-54027-2_16 · Cited by 4
Johnson, M. A. A., & Coutinho, H. D. M. (2023) · Vegetos · doi:10.1007/s42535-023-00704-3 · Cited by 4
BDNF/TrkB Signaling and Epileptogenesis
Harward, S. C., Huang, Y. Z., & McNamara, J. O. (2024) · Oxford University Press eBooks · doi:10.1093/med/9780197549469.003.0032 · Cited by 3
Stimulating Neurotrophin Receptors in the Treatment of Neurodegenerative Disorders
Nordvall, G., & Forsell, P. K. A. L. (2014) · Annual reports in medicinal chemistry · doi:10.1016/b978-0-12-800167-7.00005-5 · Cited by 3
Wiart, C. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-398373-2.00002-9 · Cited by 3
7,8-Dihydroxyflavone Protects PC12 Cells against MPP+-Induced Cytotoxicity by Heme Oxygenase-1
Song, Y., & Han, X. (2019) · International Journal of Sciences · doi:10.18483/ijsci.1932 · Cited by 2
Vink, H. A., Ramekers, D., Foster, A. C., & Versnel, H. (2023) · Hearing Research · doi:10.1016/j.heares.2023.108895 · Cited by 2
Palioura, S., & Demetrios, G. (2013) · InTech eBooks · doi:10.5772/54294 · Cited by 1
PVA-Based Scaffolds for Controlled Release of Neuroprotective Compounds
Visser, Z. (2021) · DalSpace (Dalhousie University) · Cited by 1
TrkB Activators for the Treatment of Traumatic Vision Loss
Iuvone, P. M., & Diamond, B. (2013) · Defense Technical Information Center (DTIC) · doi:10.21236/ada606287
Charunayan Kamath, R., & Archanna, J. (2021) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/jvrf2
Charunayan Kamath, R., & Archanna, J. (2021) · OSF Preprints (OSF Preprints) · doi:10.31219/osf.io/wtvm3
Establishment of a human iPS cell-derived neuronal model cell to study synaptic signaling
Traub, S. (2020) · KOPS (University of Konstanz)
Metadata
- Authors
- Jang, S.-W., Liu, X., Chan, C. B., France, S. A., Sayeed, I., Tang, W., Lin, X., Xiao, G., Andero, R., Chang, Q., Ressler, K. J., & Ye, K.
- Affiliations
- Emory University (US)
- Georgia Institute of Technology (US)
- Centers for Disease Control and Prevention (US)
- University of Wisconsin–Madison (US)
- Howard Hughes Medical Institute (US)
- Corresponding author
- Ye, Keqiang
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2010-07-13
- Volume
- 5
- Issue
- 7
- Pages
- e11528
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2903477
- OpenAlex
- W2000508433
- Cited by
- 101
- References
- 52
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 5 · 2023: 7 · 2022: 7 · 2021: 5 · 2020: 8 · 2019: 7 · 2018: 2 · 2017: 6 · 2016: 7 · 2015: 4 · 2014: 9 · 2013: 17 · 2012: 6
- FWCI
- 3.48
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Dipòsit Digital de Documents de la UAB (Universitat Autònoma de Barcelona) (submittedVersion, cc-by)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- The HKU Scholars Hub (University of Hong Kong) (submittedVersion, cc-by-nc-nd)
- Funders
- National Cancer Institute (R01CA127119)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacological Receptor Mechanisms and Effects
- Keywords
- gedunin, TrkB receptor, neurotrophic activity, neuroprotection, neuronal cell death, antidepressant effects, learning improvement, oral bioavailability
- MeSH terms
- Animals, Antidepressive Agents, Cell Line, Cells, Cultured, Hippocampus, Humans, Immunohistochemistry, Male, Mice, Inbred C57BL, Mice, Mutant Strains, Neurons, Protein Binding, Apoptosis, Protein Structure, Tertiary, Brain-Derived Neurotrophic Factor, Receptor, trkB, Limonins, Cell Line, Tumor, Mice, Rats, Protein Multimerization
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.